lamotrigine 200mg tablets
milpharm ltd - lamotrigine - oral tablet - 200mg
sertraline 50mg tablets
milpharm ltd - sertraline hydrochloride - oral tablet - 50mg
sertraline 100mg tablets
milpharm ltd - sertraline hydrochloride - oral tablet - 100mg
tramadol 50mg capsules
milpharm ltd - tramadol hydrochloride - oral capsule - 50mg
citalopram 10mg tablets
milpharm ltd - citalopram hydrobromide - oral tablet - 10mg
citalopram 20mg tablets
milpharm ltd - citalopram hydrobromide - oral tablet - 20mg
citalopram 40mg tablets
milpharm ltd - citalopram hydrobromide - oral tablet - 40mg
kaletra oral solution
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - solution (oral) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
kaletra oral solution
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - solution (oral) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
skyrizi 75 mg
abbvie biopharmaceuticals ltd, israel - risankizumab - solution for injection - risankizumab 75 mg / 0.83 ml - risankizumab - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who arecandidates for systemic therapy.psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of activepsoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards).